SUITOR
SUITOR estimates the optimal number of de novo mutational signatures in cancer genomics datasets using an unsupervised cross-validation framework to guide signature selection.
Key Features:
- De novo mutational signature analysis: Performs de novo extraction of mutational signatures from mutation catalogs.
- Optimal signature number selection: Determines the optimal number of mutational signatures present in a dataset.
- Unsupervised cross-validation: Employs an unsupervised cross-validation methodology to evaluate signature models.
- Minimizes assumptions: Minimizes methodological assumptions during cross-validation.
- Avoids numerical approximations: Avoids numerical approximations to reduce potential estimation bias.
- Prediction-error minimization: Selects signatures by identifying models with the smallest prediction errors.
- Overfitting reduction: Reduces the risk of overfitting through its cross-validation-based selection criterion.
- Validation in vitro and in silico: Performance has been validated using in vitro experiments and in silico simulations.
- Application to whole-genome sequencing: Has been applied to 2,540 whole-genome sequenced tumors across 22 cancer types.
- Independent breast cancer corroboration: Identified signatures were corroborated in an independent breast cancer study.
Scientific Applications:
- Etiological inference: Supports inference of mutational processes underlying cancer development.
- Therapeutic implication analysis: Facilitates investigation of potential therapeutic implications of mutational signatures.
- Large-cohort signature discovery: Enables signature discovery and selection in large whole-genome sequencing cohorts, including multi-cancer and breast cancer studies.
- Downstream analytical accuracy: Improves accuracy of downstream analyses that depend on correct signature number estimation.
Methodology:
Performs de novo mutational signature extraction combined with an unsupervised cross-validation framework that minimizes assumptions, avoids numerical approximations, and selects the number of signatures by minimizing prediction error.
Topics
Details
- License:
- Not licensed
- Cost:
- Free of charge
- Tool Type:
- library
- Operating Systems:
- Mac, Linux, Windows
- Programming Languages:
- R
- Added:
- 7/14/2022
- Last Updated:
- 11/24/2024
Operations
Publications
Lee D, Wang D, Yang XR, Shi J, Landi MT, Zhu B. SUITOR: Selecting the number of mutational signatures through cross-validation. PLOS Computational Biology. 2022;18(4):e1009309. doi:10.1371/journal.pcbi.1009309. PMID:35377867. PMCID:PMC9009674.